Evaluation of Docosahexaenoic Acid in a Dog Model of Hypertension Induced Left Ventricular Hypertrophy
- 25 September 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Cardiovascular Translational Research
- Vol. 6 (6), 1000-1010
- https://doi.org/10.1007/s12265-013-9511-y
Abstract
Marine n-3 polyunsaturated fatty acids alter cardiac phospholipids and prevent cardiac pathology in rodents subjected to pressure overload. This approach has not been evaluated in humans or large animals with hypertension-induced pathological hypertrophy. We evaluated docosahexaenoic acid (DHA) in old female dogs with hypertension caused by 16 weeks of aldosterone infusion. Aldosterone-induced hypertension resulted in concentric left ventricular (LV) hypertrophy and impaired diastolic function in placebo-treated dogs. DHA supplementation increased DHA and depleted arachidonic acid in cardiac phospholipids, but did not improve LV parameters compared to placebo. Surprisingly, DHA significantly increased serum aldosterone concentration and blood pressure compared to placebo. Cardiac mitochondrial yield was decreased in placebo-treated hypertensive dogs compared to normal animals, which was prevented by DHA. Extensive analysis of mitochondrial function found no differences between DHA and placebo groups. In conclusion, DHA did not favorably impact mitochondrial or LV function in aldosterone hypertensive dogs.Keywords
This publication has 36 references indexed in Scilit:
- Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell deathAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Dietary supplementation with docosahexaenoic acid, but not eicosapentaenoic acid, dramatically alters cardiac mitochondrial phospholipid fatty acid composition and prevents permeability transitionBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Treatment with Docosahexaenoic Acid, but Not Eicosapentaenoic Acid, Delays Ca2+-Induced Mitochondria Permeability Transition in Normal and Hypertrophied MyocardiumThe Journal of pharmacology and experimental therapeutics, 2010
- Effects of dietary omega–3 fatty acids on ventricular function in dogs with healed myocardial infarctions: in vivo and in vitro studiesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Dietary ω-3 fatty acids alter cardiac mitochondrial phospholipid composition and delay Ca2+-induced permeability transitionJournal of Molecular and Cellular Cardiology, 2009
- Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunctionCardiovascular Research, 2008
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialThe Lancet, 2008
- Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylationCardiovascular Research, 2008
- Dietary supplementation with ω-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overloadCardiovascular Research, 2007